ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages

Jinlong Yin,Sung Soo Kim,Eunji Choi,Young Taek Oh,Weiwei Lin,Tae-Hoon Kim,Jason K. Sa,Jun Hee Hong,Se Hwan Park,Hyung Joon Kwon,Xiong Jin,Yeonhee You,Ji Hye Kim,Hyunggee Kim,Jaekyoung Son,Jeongwu Lee,Do-Hyun Nam,Kui Son Choi,Bingyang Shi,Ho-Shin Gwak,Heon Yoo,Antonio Iavarone,Jong Heon Kim,Jong Bae Park
DOI: https://doi.org/10.1038/s41467-020-16789-2
IF: 16.6
2020-06-12
Nature Communications
Abstract:Abstract The interplay between glioblastoma stem cells (GSCs) and tumor-associated macrophages (TAMs) promotes progression of glioblastoma multiforme (GBM). However, the detailed molecular mechanisms underlying the relationship between these two cell types remain unclear. Here, we demonstrate that ARS2 (arsenite-resistance protein 2), a zinc finger protein that is essential for early mammalian development, plays critical roles in GSC maintenance and M2-like TAM polarization. ARS2 directly activates its novel transcriptional target MGLL , encoding monoacylglycerol lipase (MAGL), to regulate the self-renewal and tumorigenicity of GSCs through production of prostaglandin E 2 (PGE 2 ), which stimulates β-catenin activation of GSC and M2-like TAM polarization. We identify M2-like signature downregulated by which MAGL-specific inhibitor, JZL184, increased survival rate significantly in the mouse xenograft model by blocking PGE 2 production. Taken together, our results suggest that blocking the interplay between GSCs and TAMs by targeting ARS2/MAGL signaling offers a potentially novel therapeutic option for GBM patients.
multidisciplinary sciences
What problem does this paper attempt to address?